Publication of Clinical Research (L11; E3)
20 Questions
7 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary ethical responsibility of the investigator in clinical research?

  • To ensure the design and execution of the study protects the patient's rights. (correct)
  • To follow the sponsor's protocol exactly without changes.
  • To minimize the duration of the study to reduce costs.
  • To ensure the study includes as many participants as possible.

Why is it important for investigators not to simply accept sponsor-drafted protocols?

  • Sponsors are typically experts in research designs.
  • Investigators may produce biased results if they do.
  • Protocols can be too complex for investigators to understand.
  • It can compromise the quality and objectivity of the research. (correct)

Which of the following is a critical aspect of defining end points in a clinical trial?

  • End points should be flexible to accommodate changes during the trial.
  • Stopping points should be determined after preliminary results.
  • End points must provide evidence of the treatment’s efficacy. (correct)
  • End points should only reflect patient satisfaction outcomes.

What potential issue arises from having too favorable inclusion and exclusion criteria in a study?

<p>It may lead to results that do not represent the general population. (D)</p> Signup and view all the answers

How should randomization be structured in clinical trials?

<p>The mechanism of randomization must be well-defined and double blinded. (A)</p> Signup and view all the answers

What is a potential consequence of failing to publish negative trial results?

<p>Continuation of harmful patient treatment. (A)</p> Signup and view all the answers

What is one requirement that should be established before a clinical study begins?

<p>A publication committee among the principal investigators. (A)</p> Signup and view all the answers

How should companies handle reports of serious adverse events in clinical trials?

<p>They should circulate reports to all investigators promptly. (B)</p> Signup and view all the answers

What is a common issue related to the publication of negative trial results?

<p>They are frequently ignored or not submitted for publication. (D)</p> Signup and view all the answers

What timeframe should a company typically allow for review before publishing study results?

<p>90 days. (D)</p> Signup and view all the answers

What is one of the recommendations made by the AMA regarding investigators in industry-sponsored research?

<p>Investigators should not hold stock or stock options in the sponsoring company. (C)</p> Signup and view all the answers

What is the purpose of nondisclosure agreements in the context of industry-supported research?

<p>To protect the company's proprietary information from being disclosed. (B)</p> Signup and view all the answers

Which clause is particularly important to review when entering a research contract to ensure patient safety?

<p>The clause regarding publication rights. (C)</p> Signup and view all the answers

What is one of the responsibilities of the Institutional Review Board (IRB) in clinical research?

<p>To approve the study design as scientifically valid (B)</p> Signup and view all the answers

What issue was highlighted by the Olivieri case regarding contract agreements in clinical research?

<p>Contracts can impose severe restrictions on the disclosure of research information. (B)</p> Signup and view all the answers

Why is frequent reporting from the data-monitoring committee important during a clinical trial?

<p>To detect unexpected complications and maintain patient safety (B)</p> Signup and view all the answers

Which of the following is a potential consequence for investigators from nondisclosure agreements?

<p>They might lose the ability to publish their findings. (C)</p> Signup and view all the answers

What potential issue arises when a company controls the data in clinical research?

<p>Investigators might lack access to raw data for comprehensive analysis (D)</p> Signup and view all the answers

What role does the data-monitoring committee play in clinical trials?

<p>To protect patient interests and ensure ethical conduct (A)</p> Signup and view all the answers

What is a common problem associated with the summarized analysis provided by the company to investigators?

<p>Investigators often cannot access raw data to respond adequately to reviewers (D)</p> Signup and view all the answers

Flashcards

Industry-funded research conflicts

Potential conflicts of interest arise when researchers are supported by companies whose products or services are being studied.

Investigator conflicts of interest

Researchers should avoid owning company stock or holding officer positions in companies funding their research.

Post-research stock offerings

Companies can provide stock to researchers as recognition for contributions, but only after the research is complete.

Nondisclosure agreements (NDAs)

Legal agreements preventing researchers from sharing confidential company information.

Signup and view all the flashcards

Research contract review

Investigators must carefully review research contracts, especially clauses regarding publication, data access, and conflict resolution.

Signup and view all the flashcards

Ethical responsibility of researchers

Researchers have a duty to design and conduct studies protecting patient rights and producing meaningful data, not blindly accepting sponsor protocols.

Signup and view all the flashcards

Bias in inclusion/exclusion criteria

Clinical trials can be biased by including only patients likely to respond favorably to the treatment, potentially masking true effectiveness.

Signup and view all the flashcards

Importance of blinding and randomization

Clinical trials must utilize double-blind procedures and methods of randomization (defined mechanism) to avoid bias in results.

Signup and view all the flashcards

Critical role of end points

Chosen end points in a trial must demonstrate treatment effectiveness, be realistic, and have a defined stopping point.

Signup and view all the flashcards

Cost considerations in clinical trials

Clinical trials must address cost, ensuring sufficient patients and follow-up for meaningful results; conflicts of interest (COI) should be carefully managed and the IRB should review contracts.

Signup and view all the flashcards

IRB's role in research

The Institutional Review Board (IRB) ensures ethical research by reviewing study design, patient consent, risk-benefit analysis, financial arrangements, and monitoring progress.

Signup and view all the flashcards

Data monitoring committee

A committee that oversees data collection, analysis, and safety in clinical research, protecting patients' interests and ensuring accurate results.

Signup and view all the flashcards

Data control in industry-funded research

Companies often control the data in industry-funded research, potentially hindering independent analysis and investigator transparency.

Signup and view all the flashcards

Company's role in data analysis

Companies often only provide summarized data to investigators for presentations and publications, limiting independent analysis and scrutiny.

Signup and view all the flashcards

FDA approval vs. publication

The FDA may approve drugs before publication of research, raising concerns about scientific transparency and independent verification.

Signup and view all the flashcards

Interim Data Release

Sharing preliminary research findings before full study completion. Can create misleading expectations or discourage further study.

Signup and view all the flashcards

Negative Trials

Research studies where the treatment does not show a positive effect. Often suppressed or difficult to publish.

Signup and view all the flashcards

Delays in Publication

Industry-funded studies may face delays in publishing results if they are unfavorable to the company.

Signup and view all the flashcards

Multiple Publications

Publishing the same data repeatedly, but with different starting points, can make the results confusing and misleading.

Signup and view all the flashcards

Publication Committee

A group of researchers established to ensure timely and unbiased publication of research results.

Signup and view all the flashcards

Study Notes

Publication of Clinical Research

  • 58% of published randomized controlled trials (RCTs) are non-industry sponsored, while 42% are industry sponsored. (Gross et al., 2002)
  • Complex interactions exist between industry, investigators, patients, regulatory bodies, and other stakeholders in clinical research. (Rutherford, 2000)

Types of Conflicts

  • Non-financial conflicts include:
    • Desire to prove prior hypotheses were correct
    • Self-promotion/peer recognition
    • Political agendas
    • Religious beliefs
  • Financial conflicts include:
    • Study support
    • Investigator support to conduct a study
    • Royalties/patents
    • Expert Witness
    • "Insider" information

Prevalence of Financial Conflicts

  • 22% of community internists participated in industry trials in 2003.
  • 28% of faculty received industry research funds in 1996.
  • 124 academic institutions held equity in businesses engaged in research at the same institution.
  • 36% of IRB members had financial conflicts in 2006. (Ashar et al., 2004; Blumenthal et al., 1996; Campbell et al., 2006)

Financial Conflict of Interest

  • Defined as situations where financial considerations compromise or appear to compromise an investigator's judgment in conducting or reporting research. (1990 AAMC Guidelines)
  • Authors' published opinions strongly correlate with their financial arrangements. (Gross, 200X)

Study Design Bias

  • Example: Fluconazole vs. amphotericin B, where 92% of trial patients were in trials sponsored by the manufacturer of fluconazole. (Johansen et al., 20XX)
  • Oral amphotericin was a poorly absorbed comparison agent rarely used for systemic infections.
  • Fluconazole shows a wonder-drug effect compared to the poorly performing control.

Systematic Review: Industry Sponsorship vs. Study Outcome

  • Industry-supported studies often had a hazard ratio greater than one, suggesting a positive impact. (Bekelman et al., 2003)

Financial Conflicts in Research

  • Financial conflicts in research are pervasive, powerful, clinically hazardous, and threaten scientific integrity.

Potential Problems with Industry-Supported Clinical Research

  • Financial conflicts of interest
  • Nondisclosure agreements
  • Research contracts
  • Development of research protocols
  • Comparative groups (inclusion/exclusion criteria)
  • Blinding and randomization
  • End points
  • Cost considerations
  • Institutional review board (IRB) approval
  • Data analysis
  • Data collection, analysis, and control of data (data monitoring committee)
  • Interim data release
  • Presentation and publication of data
  • Adverse events
  • Delays in publication
  • Multiple publications
  • Publication committees
  • Contract complexity and potential for investigator rights/integrity issues

Case Studies

  • The Olivieri case highlights issues with financial conflicts and contracts. (Rutherford, 2000)
  • The Rhone-Poulenc-Rorer case demonstrates a more positive relationship between industry and investigator. (Rutherford, 2000)

Journals

  • Journals emphasize author independence, objective data analysis, and publication bias.

Trial Registration

  • Trial registration is required for trials and includes details like hypothesis, interventions, endpoints, eligibility criteria, and funding sources. (ICMJE, 2005)

JAMA Policy Regarding Data Analysis

  • Industry-sponsored studies must have independent statisticians who are identified and provided with the entire raw data set, study protocol, and analytic plan.

Disclosure to Participants

  • Consent forms should disclose conflicts of interest, with committee oversight.
  • A 2004 survey of IRBs found that disclosure was suggested by 48% of IRBs in surveys but oversaw financial conflicts by only 4%.

Types of Scientific Misconduct from Self-Reports

  • Overinterpretation
  • Selective reporting
  • Subgroup analyses
  • Negative outcomes
  • Inappropriate subgroup analysis
  • Reporting issues
  • Analysis by sponsor

Publication Standards

  • Editorial oversight and independent investigations are key for controlling misconduct.
  • Consolidated Standards of Reporting Trials (CONSORT) guidelines improve clinical trial reporting.

Methods to Limit Ethical Misconduct in Clinical Trials

  • Pre-trial: Institutional/funding agencies take responsibility for training, contracting, monitoring, and reporting.
  • Individual/Research Teams: Use of publication standards (e.g., CONSORT).
  • Peer and Editorial Review
  • Open Access Publishing

CONSORT E-CHECKLIST

  • Detailed checklist for describing information needed in publication of clinical trials (see specific pages 30, and 31 for full list).

Meta-analysis Principles

  • All trials must be included, regardless of publication status.

  • Identification of all relevant trials is crucial

  • Randomly select trials, do not arbitrarily lump trials.

  • Reanalysis of raw data is preferred for uniform endpoints

  • Appropriate measures of trial quality should be used.

  • Sensitivity analyses are needed to evaluate robustness of conclusions.

  • Be careful lumping fundamentally different interventions into analysis

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Related Documents

Publication of Clinical Research PDF

Description

This quiz explores the essential ethical responsibilities of investigators in clinical research. It covers topics such as the importance of critically evaluating sponsor-drafted protocols and the implications of inclusion/exclusion criteria in studies. Participants will also learn about issues related to the publication of clinical trial results.

More Like This

Use Quizgecko on...
Browser
Open
Browser
Browser